PNC-27 Dosage Calculator & Research Doses

1Set Up Your Mix

20 mg/mL · 20000 mcg/mL

1. Pick your peptide

2. How much peptide is in the vial? It's printed on the label — usually something like 5 mg

3. How much water are you adding? More water makes each dose easier to measure

4. How much do you want per dose?

All answers assume a standard 1 mL U-100 syringe, where 1 unit = 0.01 mL. That is the usual insulin syringe and the one every number here is based on.

Your Answer — PNC-27Your Answer

—

50Draw To This Line

0.5That's This Many mL

1Doses In The Vial

10 mg ÷ 0.5 mL = 20 mg/mL → 10 mg ÷ 20 mg/mL = 0.5 mL → × 100 = 50 units—

Looks good. Draw to 50 units on a 1 mL syringe. That is an easy amount to measure, and this vial gives you 1 doses.

2Week-By-Week Plan — PNC-27

not applicable

When	Dose	How Often	How Many mL	Draw To	Number Of Doses	Peptide Used
Research study dose	~10 mg/kg weight-based	daily	Set by body weight — can't be turned into a single amount to draw
Community reported	10 mg	variable	0.5 mL	50 u	1 doses

No week-by-week plan for PNC-27. This one is dosed by body weight, comes ready-mixed, or only has a single dose reported — so there is nothing to work up through.

3Common Doses — PNC-27

worked out for your mix

Level	Dose	How Often	How Many mL	Draw To	Doses In Vial

Please read this. These numbers come from published research. They are here as reference, not as instructions. A lot of them come from lab studies rather than studies in people, and some of these peptides have never been given to a person at all.

About PNC-27About This Peptide

Immune & Anti-microbial

Also known as

p53-derived HDM-2 binding peptide

Class

Immune & Anti-microbial

Route

Subcutaneous

Half-life

Short

Evidence tier

Preclinical

A p53-derived peptide fused to a membrane-penetrating sequence, reported to selectively lyse cancer cell membranes in vitro and in preclinical tumour models. There are no human trials. Marketing of this compound as a cancer treatment substantially outruns its evidence.

Buy PNC-27this peptide

Opens optimal-pep.com in a new tab

Where These Numbers Come From

Preclinical — Preclinical and in-vitro data only — no human dosing trials

PNC-27 induces cancer cell necrosis via HDM-2 membrane interaction Michl J, Sarafraz-Yazdi E, Pincus MR, et al. Journal of Molecular Medicine / PLOS ONE, 2006–2019

The originating and follow-up in vitro and preclinical work.

Find on PubMed ↗

Newest Studies — —

—

Not reviewed by us. This list is pulled straight from Europe PMC as papers are published. Nobody has checked whether these are any good, or whether they change anything above. The dose numbers on this page only ever change after a person reviews the evidence.

More peptides

Browse the full catalogue, or jump to a neighbouring compound.

Research Use Only — Confirm to Continue

PNC-27 Dosage & Reconstitution